by xplorelab | Mar 29, 2023 | Ottawa Hospital Research Institute, Research, The Ottawa Hospital
Dr. Thébaud’s team has treated the first patient in an innovative cell therapy clinical trial – the first of its kind in the world – that aims to prevent very premature babies from developing a chronic lung disease called bronchopulmonary dysplasia (BPD)....
by xplorelab | Sep 22, 2022 | Ottawa Hospital Research Institute, Research, The Ottawa Hospital
A new publication uncovers clues as to why preterm babies with bronchopulmonary dysplasia (BPD) may have problems learning, thinking and remembering. A study led by former Xplore Lab team member Dr. Marissa Lithopoulos found that extra oxygen damaged the structure and...
by xplorelab | Nov 4, 2020 | Funding, Ottawa Hospital Research Institute, Research, The Ottawa Hospital
A gene therapy in development by researchers at The Ottawa Hospital, CHEO and uOttawa in collaboration with the University of Guelph, is showing dramatic results in mice with this disorder, improving their life expectancy from two days to over six months, according to...
by xplorelab | Apr 8, 2019 | Research, The Ottawa Hospital
Dr. Bernard Thébaud’s research on a stem cell treatment that may help heal the lungs of premature babies was featured by The Ottawa Hospital Foundation.
by xplorelab | Jun 29, 2018 | Media, Ottawa Hospital Research Institute, Research, The Ottawa Hospital
Marissa Lithopoulos was featured on The Ottawa Hospital’s website for her work with the Let’s Talk Science outreach program, for which she has been a volunteer since 2014. This year marks the 25th anniversary of the University of Ottawa chapter of this...
by xplorelab | Jun 1, 2017 | Funding, Media, Ottawa Hospital Research Institute, Research, The Ottawa Hospital
Dr. Bernard Thébaud and colleagues have been awarded $550,000 from the Ontario Institute for Regenerative Medicine (OIRM) to further their research in order to prepare for a clinical trial of umbilical cord stem cell therapy for premature babies with BPD, the most...